← Back to Search

Platelet-rich Plasma Therapy

Platelet-rich Plasma Therapy for Hair Loss

Phase < 1
Waitlist Available
Led By Rita Pichardo, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Not currently on any treatment for alopecia, or has undergone 2-week washout period if recently on medication(s) for alopecia
Female ≥18 years of age at baseline visit.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will test whether a special blood product can help treat hair loss in women.

Who is the study for?
This trial is for women over 18 with androgenic alopecia who aren't currently treating their hair loss or have stopped treatments for at least two weeks. Participants must be able to follow the study's procedures and give written consent. Women can't join if they're pregnant, breastfeeding, have anemia, are on blood thinners, have certain skin conditions like psoriasis, infections or metastatic diseases.Check my eligibility
What is being tested?
The trial is testing platelet-rich plasma therapy on either side of the scalp to see how effective it is in treating female pattern hair loss. Platelet-rich plasma is made from a participant's own blood.See study design
What are the potential side effects?
Potential side effects may include discomfort at injection sites, infection risk due to injections, possible worsening of existing skin conditions like psoriasis if present elsewhere on the body.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not currently treating my hair loss, or I stopped any treatments at least 2 weeks ago.
Select...
I am a woman aged 18 or older.
Select...
I have been diagnosed with hair loss due to male or female pattern baldness.
Select...
I am a woman aged 18 or older.
Select...
I have been diagnosed with hair loss due to androgenic alopecia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Severity of Alopecia Tool (SALT) from baseline
Secondary outcome measures
Change in Hair Count (number of hairs/0.65cm^2)
Change in Hair Density (number of hairs/cm^2)
Other outcome measures
Anagen to Telogen Ratio
Change in Dermatology Life Quality Index (DLQI)
Change in Hair Diameter
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group BExperimental Treatment1 Intervention
At the baseline visit subjects will be randomized to either group A or group B. Group B will receive PRP on right side of scalp and placebo (saline solution) on left side of scalp.
Group II: Group AExperimental Treatment1 Intervention
At the baseline visit subjects will be randomized to either group A or group B. Group A will receive PRP on left side of scalp and placebo (saline solution) on right side of scalp.

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,231 Previous Clinical Trials
1,001,797 Total Patients Enrolled
Rita Pichardo, MDPrincipal InvestigatorWake Forest University School of Medicine, Department of Dermatology

Media Library

Platelet-rich Plasma (Platelet-rich Plasma Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT03474718 — Phase < 1
Male Pattern Baldness Research Study Groups: Group A, Group B
Male Pattern Baldness Clinical Trial 2023: Platelet-rich Plasma Highlights & Side Effects. Trial Name: NCT03474718 — Phase < 1
Platelet-rich Plasma (Platelet-rich Plasma Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03474718 — Phase < 1
Male Pattern Baldness Patient Testimony for trial: Trial Name: NCT03474718 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to sign up for this research endeavor?

"At the current time, this clinical trial is not actively recruiting patients. Although it was initially posted on January 1st 2023 and last modified November 28th 2022; however, 86 other medical trials are currently enrolling individuals."

Answered by AI

Who else is applying?

What state do they live in?
New York
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I can't use minoxidil and spironolactone due to low bp. Would like to try an alternative like PRP.
PatientReceived no prior treatments
I've been experiencing hair thinning and hair loss and I would like to act before it gets too late.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

Can I be a part of this trial and reside in NYC?
PatientReceived 1 prior treatment
~11 spots leftby Jun 2024